Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
暂无分享,去创建一个
Xueli Yang | Fangchao Liu | Jianxin Li | Xiao-qing Liu | Jie Cao | Lin Yu | F. Lu | Xian-ping Wu | Xi-gui Wu | D. Hu | Jianfeng Huang | Xiangfeng Lu | Y. Li | Chong Shen | D. Gu | Lian-cheng Zhao | Jichun Chen
[1] Alan D. Lopez,et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.
[2] Jiang He,et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. , 2015, Circulation.
[3] Bing Zhang,et al. Prevalence and Secular Trends in Obesity Among Chinese Adults, 1991-2011. , 2015, American journal of preventive medicine.
[4] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Journal of the American College of Cardiology.
[5] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[6] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[7] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[8] Jiang He,et al. Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.
[9] Alan D. Lopez,et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.
[10] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[11] G. Boysen,et al. European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.
[12] Zuo Chen,et al. Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults , 2006, Circulation.
[13] Shengshou Hu,et al. Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China: Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia) , 2005, Circulation.
[14] Dong Zhao,et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. , 2004, JAMA.
[15] Majid Ezzati,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[16] K. Thygesen,et al. Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969)) , 2001 .
[17] J S Alpert,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, Journal of the American College of Cardiology.
[18] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[19] W. Kannel,et al. A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.
[20] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.
[21] Dawber Tr. Summary of recent literature regarding cigarette smoking and coronary heart disease. , 1960, Circulation.
[22] A. Hoes,et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.
[23] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[24] T. Dawber. Summary of recent literature regarding cigarette smoking and coronary heart disease. , 1960, Circulation.